1、湘潭永达机械制造股份有限公司（以下简称"公司"）拟以发行股份及 支付现金的方式向葛艳明（以下简称"交易对方"）购买其持有的江苏金源高端 装备有限公司49.00%股权，同时募集配套资金（以下简称"本次交易"）。公司 于2025年12月9日披露的《湘潭永达机械制造股份有限公司发行股份及支付现金 购买资产并募集配套资金暨关联交易预案》及其摘要中，详细披露了本次交易尚 需履行的审批程序及涉及的风险因素，敬请广大投资者注意投资风险。 2、自本次交易预案披露以来，公司及交易相关方积极推进本次交易的相关 工作。截至本公告披露日，除已披露的风险因素外，公司尚未发现可能导致公司 董事会或者交易对方撤销、中止本次交易或者对本次交易方案作出实质性变更的 相关事项。本次交易相关工作正在有序进行中，公司将继续积极推进本次交易， 并根据中国证券监督管理委员会和深圳证券交易所的相关规定及时履行本次交 易的后续审批和信息披露程序。 一、本次交易概述 公司拟以发行股份及支付现金的方式向葛艳明购买其持有的江苏金源高端装 备有限公司49.00%股权，同时募集配套资金。 证券代码：001239 证券简称：永达股份 公告编号：2026-004 湘 ...

Group 1 - The company held its 12th meeting of the second board on January 6, 2026, where it approved the use of up to RMB 350 million of temporarily idle raised funds for cash management [2][23] - The board authorized the management to make investment decisions and sign relevant contracts for cash management, which includes selecting qualified financial products and determining investment amounts and periods [17][22] - The company plans to invest in low-risk financial products with high safety and liquidity, such as structured deposits and time deposits, ensuring that the investment does not affect the ongoing projects funded by the raised capital [13][16] Group 2 - The company will open a new special account for raised funds at Guangfa Bank to facilitate cash management and ensure compliance with regulatory requirements [30][32] - The establishment of the new account is intended to optimize the management of raised funds and will not be used for non-raised funds or other purposes [32][34] - The board and the audit committee have approved the establishment of the new account, ensuring that it aligns with relevant laws and regulations [34][35]

国泰海通证券股份有限公司 关于湘潭永达机械制造股份有限公司 使用闲置募集资金进行现金管理的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐人"）作为湘 潭永达机械制造股份有限公司（以下简称"永达股份""公司"或"本公司"） 首次公开发行股票并上市持续督导的保荐人，根据《证券发行上市保荐业务管理 办法》及《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》等有关规定，就公司使用闲置募集资金进行现金管理进行了核查，具体情 况如下： 一、募集资金基本情况 经中国证券监督管理委员会注册同意（证监许可[2023]1854号），并经深圳证 券交易所《关于湘潭永达机械制造股份有限公司人民币普通股股票上市的通知》（ 深证上[2023]1126号）同意，公司向社会公众公开发行人民币普通股（A股）60,000,000 股，每股面值人民币1.00元，每股发行价格人民币12.05元，募集资金总额为人民币 723,000,000.00元，扣除发行费用（不含增值税）人民币86,805,438.47元后，实际募 集资金净额为人民币636,194,561.53元。天职国际会计师事务所（特殊普通合伙）已 ...

一、募集资金基本情况 根据中国证券监督管理委员会《关于同意湘潭永达机械制造股份有限公司首 次公开发行股票注册的批复》（证监许可[2023]1854 号），公司首次向社会公众公 开发行人民币普通股（A 股）股票 6,000.00 万股，本次发行价格为每股人民币 12.05 元，募集资金总额为人民币 72,300.00 万元，扣除不含税发行费用 8,680.54 万元 后，募集资金净额为 63,619.46 万元。上述募集资金到位情况已经天职国际会计师 事务所（特殊普通合伙）审验，于 2023 年 12 月 6 日出具天职业字[2023]51912 号 《验资报告》。 为规范公司募集资金管理，保护投资者权益，公司与保荐机构、募集资金专 户开户银行签署了《募集资金三方监管协议》，开设了募集资金专项账户，对募 集资金实行专户存储。上述募集资金已按规定全部存放于公司募集资金专户。 截至 2026 年 1 月 6 日，公司募集资金专用账户的开立情况如下： 证券代码：001239 证券简称：永达股份 公告编号：2026-002 湘潭永达机械制造股份有限公司关于新增 募集资金专用账户并授权管理层签订三方监管协议的公告 本公司 ...

证券代码：001239 证券简称：永达股份 公告编号：2026-001 湘潭永达机械制造股份有限公司 关于使用闲置募集资金进行现金管理的公告 经中国证券监督管理委员会注册同意（证监许可[2023]1854号），并经深圳证 券交易所《关于湘潭永达机械制造股份有限公司人民币普通股股票上市的通知》（ 深证上[2023]1126号）同意，公司向社会公众公开发行人民币普通股（A股）60,000,000 股，每股面值人民币1.00元，每股发行价格人民币12.05元，募集资金总额为人民币 723,000,000.00元，扣除发行费用（不含增值税）人民币86,805,438.47元后，实际募 集资金净额为人民币636,194,561.53元。天职国际会计师事务所（特殊普通合伙）已 于2023年12月6日对公司募集资金到位情况进行了审验，并出具了"天职业字【2023】 51912号"《湘潭永达机械制造股份有限公司验资报告》。上述募集资金已全部存放 于公司开立的募集资金专项账户，公司已与保荐人、存放募集资金的商业银行签署 募集资金三方监管协议。 二、募集资金使用情况 截至2026年1月6日，公司募集资金使用情况如下： 单位：元 ...

证券代码：001239 证券简称：永达股份 公告编号：2026-003 湘潭永达机械制造股份有限公司 第二届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 湘潭永达机械制造股份有限公司（以下简称"公司"）第二届董事会第十二次会 议于2026年1月6日（星期二）在公司三楼会议室以现场表决的方式召开。会议通 知已于2026年1月4日以微信或电子邮件方式送达全体董事，本次会议为紧急会议， 经公司全体董事一致同意，本次董事会会议豁免通知时限要求。本次会议应出席 董事7人，实际出席董事7人。会议由董事长沈培良先生主持，高级管理人员列席。 会议召开符合有关法律、法规、规章和《公司章程》的规定。经各位董事认真审 议，会议形成了如下决议： 二、董事会会议审议情况 （一）审议通过《关于使用暂时闲置募集资金进行现金管理的议案》 全体董事一致同意公司使用不超过人民币 3.5 亿元（含本数）的暂时闲置募 集资金适时进行现金管理，在上述额度范围内，该额度可循环使用。上述额度自 董事会审议通过之日起 12 个月内可循环滚动使用，公司授权 ...

Core Viewpoint - The company has approved the use of idle raised funds for cash management, allowing for investment in low-risk, liquid financial products [1] Group 1: Financial Management - The company will utilize up to 350 million yuan of temporarily idle raised funds for cash management [1] - The approved financial products include structured deposits, large certificates of deposit, time deposits, notice deposits, and agreement deposits [1] - The validity of the approved amount is effective for 12 months from the date of the board's approval, with the funds being available for rolling use within this limit [1] Group 2: Impact on Operations - The company states that this decision will not affect the progress of the investment projects funded by the raised capital or the normal production and operation of the company [1]

Group 1 - The company, Yongda Co., has been awarded a pre-bid confirmation for the procurement project of "cabin platform (rear seat)" for the year 2026 by Mingyang Smart Energy Group Co., Ltd. [1] - The order period for the project is set for one year, with an expected total cooperation volume of approximately 2,100 units. [1] - The total bid amount for the project is estimated to be around 350 million yuan. [1]

Group 1 - The company, Xiangtan Yongda Machinery Manufacturing Co., Ltd., has been awarded a bid for the 2026 annual procurement project of "cabin platform (rear seat)" by Mingyang Smart Energy Group Co., Ltd. [1] - The project involves a total order quantity of approximately 2,100 units, including 1,700 onshore models and 400 offshore models, with a total bid amount of about 350 million yuan [1][2] - The company does not have any related party relationship with the bidder, ensuring independence in its business operations [1][2] Group 2 - The bid win is expected to positively impact the company's future operating performance, particularly as the demand for clean energy equipment continues to rise amid the global energy transition [2] - The cabin platform is a core component of offshore wind power equipment, and its market demand is steadily increasing, aligning with the company's main business focus [2]

Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]